Skip to Main Content

Author Details

Ernest T Hawk
The University of Texas MD Anderson Cancer Center
1995
197
57
PMIDPaper TitleJournal TitlePublished Year
34130548Addressing high cervical cancer rates in the Rio Grande Valley along the Texas-Mexico border: a community-based initiative focused on education, patient navigation, and medical provider training/telementoring.Perspect Public Health2023
37540502Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma.Cancer Epidemiol Biomarkers Prev2023
37724990Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome.Clin Cancer Res2023
37672725It Doesn't Need to Take 25 Years: Emphasizing Cancer Prevention and Control in President Biden's Cancer Moonshot.JCO Oncol Pract2023
37376517Creating and Activating an Implementation Community to Drive HPV Vaccine Uptake in Texas: The Role of an NCI-Designated Cancer Center.Vaccines (Basel)2023
37403656From Premalignant Biology to Precision Interception: Connecting the Dots with a Curated Collection of Invited Articles.Cancer Prev Res (Phila)2023
36630665Ten Years of the International Cancer Control Partnership: Promoting National Cancer Control Plans to Shape the Health System Response for Cancer Control.JCO Glob Oncol2023
34633706Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease.Hepatology2022
35477306Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas.mSystems2022
36373741A Comprehensive Program to Reduce Tobacco-related Cancers Through Actions by a National Cancer Institute-designated Cancer Center.Cancer Control2022
35969832Vulvar Cancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001-2018.Cancer Prev Res (Phila)2022
36346631Development, Implementation, and Evaluation of a Distance Learning and Telementoring Program for Cervical Cancer Prevention in Cameroon.JAMA Netw Open2022
35333584Prescriptions for Mitigating Climate Change-Related Externalities in Cancer Care: A Surgeon's Perspective.J Clin Oncol2022
35133659Multicancer early detection test: Preclinical, translational, and clinical evidence-generation plan and provocative questions.Cancer2022
32314052Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study.Support Care Cancer2021
33526497Cross-sectional survey for assessing cancer care providers' characteristics and attitudes on smoking cessation in Colombia and Mexico.BMJ Open2021
34155064Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics.Cancer Epidemiol Biomarkers Prev2021
34037915Be Well Communitiesâ¿¢: mobilizing communities to promote wellness and stop cancer before it starts.Cancer Causes Control2021
32998941The Performance of Colorectal Cancer Screening in Brazil: The First Two Years of the Implementation Program in Barretos Cancer Hospital.Cancer Prev Res (Phila)2021
32778864The ASPREE Trial: An Unanticipated Stimulus for Greater Precision in Prevention?J Natl Cancer Inst2021
31605837Characteristics of us adults attempting tobacco use cessation using e-cigarettes.Addict Behav2020
32066620Using Continuous Glucose Monitoring to Motivate Physical Activity in Overweight and Obese Adults: A Pilot Study.Cancer Epidemiol Biomarkers Prev2020
33004408Rethinking Environmental Carcinogenesis.Cancer Epidemiol Biomarkers Prev2020
32912193Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development.BMC Cancer2020
32231724Patients with non-colorectal cancers may be at elevated risk of colorectal neoplasia.J Cancer2020
30700446Cancer-Related Risk Perceptions and Beliefs in Texas: Findings from a 2018 Population-Level Survey.Cancer Epidemiol Biomarkers Prev2019
31658978E-Cigarettes: Unstandardized, Under-Regulated, Understudied, and Unknown Health and Cancer Risks.Cancer Res2019
30066057A Pilot Study Evaluating Organochlorine and Organophosphate Pesticide Exposure in Children and Adolescents of Mexican Descent Residing in Hidalgo County, Texas.J Immigr Minor Health2019
29952736Building a health communication brand for University of Texas System tobacco control.J Am Coll Health2019
31231471Functional characterization of <i>CNOT3</i> variants identified in familial adenomatous polyposis adenomas.Oncotarget2019
31369653Clinical factors associated with adherence to aerobic and resistance physical activity guidelines among cancer prevention patients and survivors.PLoS One2019
31112478Mind the Gap: Precision Oncology and Its Potential to Widen Disparities.J Oncol Pract2019
30905849Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung.EBioMedicine2019
30680862Real-Time Interrogation of Aspirin Reactivity, Biochemistry, and Biodistribution by Hyperpolarized Magnetic Resonance Spectroscopy.Angew Chem Int Ed Engl2019
28607096The somatic mutation landscape of premalignant colorectal adenoma.Gut2018
29945886Molecular mechanisms of the preventable causes of cancer in the United States.Genes Dev2018
30241245Perspectives on Strengthening Cancer Research and Control in Latin America Through Partnerships and Diplomacy: Experience of the National Cancer Institute's Center for Global Health.J Glob Oncol2018
30112590Bioactive lipid metabolism in platelet "first responder" and cancer biology.Cancer Metastasis Rev2018
30412224Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2.Ann Oncol2018
30530635AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health.Cancer Prev Res (Phila)2018
29554350NSAIDs to Prevent Breast Cancer Recurrence? An Unanswered Question.J Natl Cancer Inst2018
29710228Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.JAMA Oncol2018
29393960MD Anderson's Population Health Approaches to Cancer Prevention.Tex Med2018
27829081Assessment of Compliance With Texas Legislation Banning Indoor UV Tanning by Minors.JAMA Dermatol2017
28166647Building trust and diversity in patient-centered oncology clinical trials: An integrated model.Clin Trials2017
28951454Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.Cancer Res2017
28730545Platelet "first responders" in wound response, cancer, and metastasis.Cancer Metastasis Rev2017
28674622Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic.Open Heart2017
28645942Mutational Heterogeneity in <i>APC</i> and <i>KRAS</i> Arises at the Crypt Level and Leads to Polyclonality in Early Colorectal Tumorigenesis.Clin Cancer Res2017
28762014Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.Cancer Metastasis Rev2017
  • 1 - 50 of 197

Recommended Authors

Massachusetts General Hospital and Harvard Medical School
Career Start Year 2013
Number of shared co-authors 6
University of Texas Health San Antonio
Career Start Year 2013
Number of shared co-authors 0
117902Beijing TongRen Hospital, Capital Medical University
Career Start Year 2004
Number of shared co-authors 6
National Institutes of Health
Career Start Year 2004
Number of shared co-authors 7
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 8
University of California
Career Start Year 2003
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2001
Number of shared co-authors 9
South Australian Health and Medical Research Institute
Career Start Year 2001
Number of shared co-authors 3
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Career Start Year 2001
Number of shared co-authors 3
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 5
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 10
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 3
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Career Start Year 1998
Number of shared co-authors 0
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 7
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 7
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 0
The Princess Margaret Cancer Centre/University of Toronto
Career Start Year 1992
Number of shared co-authors 9
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 2
Harvard T.H. Chan School of Public Health
Career Start Year 1990
Number of shared co-authors 19
University of Sydney
Career Start Year 1989
Number of shared co-authors 5
University of California irvine
Career Start Year 1988
Number of shared co-authors 13
Penn State College of Medicine, The Pennsylvania State University
Career Start Year 1988
Number of shared co-authors 5
University of Toronto Dalla Lana School of Public Health
Career Start Year 1988
Number of shared co-authors 13
German Cancer Research Center (DKFZ)
Career Start Year 1984
Number of shared co-authors 30
National Cancer Institute, 9609 Medical Center Dr
Career Start Year 1981
Number of shared co-authors 20
University of Alabama at Birmingham
Career Start Year 1979
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1979
Number of shared co-authors 8
Comprehensive Cancer Center, The Ohio State University
Career Start Year 1978
Number of shared co-authors 5
National Cancer Institute
Career Start Year 1977
Number of shared co-authors 7
Ontario Institute for Cancer Research
Career Start Year 1974
Number of shared co-authors 1

Collaborators

Co-authored papers 14
The University of Texas MD Anderson Cancer Center
Co-authored papers 12
Moores Cancer Center, university of california san diego
Co-authored papers 11
University of Texas MD Anderson Cancer Center
Co-authored papers 9
University of Texas M.D. Anderson Cancer Center
Co-authored papers 7
Co-authored papers 5
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 5
Co-authored papers 5
National Cancer Institute
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Co-authored papers 4
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 4
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Baylor College of Medicine
Co-authored papers 3
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 3
Tianjin First Central Hospital, Nankai University
Co-authored papers 3
Co-authored papers 3
University of Texas MD Anderson Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Karmanos Cancer Center, Wayne State University
Co-authored papers 3
Co-authored papers 2
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
University of California San Francisco
Co-authored papers 2